The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia

被引：0
|
作者：
Francesco Buccisano
Christopher S. Hourigan
Roland B. Walter
机构：
[1] University Tor Vergata,Department of Biomedicine and Prevention, Hematology
[2] National Institutes of Health,Myeloid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute
[3] Fred Hutchinson Cancer Research Center,Clinical Research Division
[4] University of Washington,Department of Medicine, Division of Hematology
[5] University of Washington,Department of Epidemiology
来源：
Current Hematologic Malignancy Reports | 2017年 / 12卷
关键词：
Acute myeloid leukemia; Flow cytometry; Minimal residual disease; Next-generation sequencing; Polymerase chain reaction; Prognostication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：547 / 556
页数：9
相关论文
共 50 条
  • [1] The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia
    Buccisano, Francesco
    Hourigan, Christopher S.
    Walter, Roland B.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 547 - 556
  • [2] PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA
    Ravandi-Kashani, Farhad
    LEUKEMIA RESEARCH, 2016, 49 : S8 - S8
  • [3] Prognostic Significance of Minimal Residual Disease in Patients with Secondary Acute Myeloid Leukemia
    How, Chi-Joan
    DiPersio, John F.
    Westervelt, Peter
    Gao, Feng
    Romee, Rizwan
    BLOOD, 2017, 130
  • [4] Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
    Marisa J. L. Aitken
    Farhad Ravandi
    Keyur P. Patel
    Nicholas J. Short
    Journal of Hematology & Oncology, 14
  • [5] Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
    Aitken, Marisa J. L.
    Ravandi, Farhad
    Patel, Keyur P.
    Short, Nicholas J.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [6] Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection
    Rajsri, Kritika Srinivasan
    Roy, Nainita
    Chakraborty, Sohini
    CANCERS, 2023, 15 (10)
  • [7] Complemental Prognostic Impact of Flow Cytometric and Molecular Quantification of Minimal/Measurable Residual Disease in Acute Myeloid Leukemia
    Kern, Wolfgang
    Meggendorfer, Manja
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2019, 134
  • [8] Clinical significance of minimal residual disease in childhood acute myeloid leukemia
    Takako Miyamura
    Naoki Sakata
    Takayuki Okamura
    Masahiro Yasui
    Masami Inoue
    Keiko Yagi
    Masahiro Sako
    Yoshihiro Komada
    Takaharu Matsuyama
    Megumi Oda
    Yong -Dong Park
    Keisei Kawa
    International Journal of Hematology, 2004, 79 : 243 - 249
  • [9] Clinical significance of minimal residual disease in childhood acute myeloid leukemia
    Miyamura, T
    Sakata, N
    Okamura, T
    Yasui, M
    Inoue, M
    Yagi, K
    Sako, M
    Komada, Y
    Matsuyama, T
    Oda, M
    Park, YD
    Kawa, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 243 - 249
  • [10] Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation
    Srour, Samer A.
    Saliba, Rima M.
    Bittencourt, Maria C. B.
    Perez, Jorge M. R.
    Kongtim, Piyanuch
    Alousi, Amin
    Al-Atrash, Gheath
    Olson, Amanda
    Betul, Oran
    Mehta, Rohtesh
    Popat, Uday
    Hosing, Chitra
    Bashir, Qaiser
    Khouri, Issa
    Kebriaei, Partow
    Masarova, Lucia
    Short, Nicholas
    Jabbour, Elias
    Daver, Naval
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop
    Champlin, Richard E.
    Ciurea, Stefan O.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1382 - 1387
12345